Business Standard

India considering to develop monkeypox vaccine; SII CEO says no rush

While 3 cases have been reported from Kerala, one was reported in the national capital. India has now started discussions with vaccine makers to develop a monkeypox vaccine

monkeypox
Premium

Photo: Shutterstock

BS Web Team New Delhi
With India still reeling under the effects of the coronavirus pandemic, another disease is now making the headlines with a spike in cases and becoming a global health threat -- monkeypox. As of Wednesday, the total confirmed cases stood at 19,188 globally. India has reported four such cases, with three from Kerala and one in the national capital.

Looking at the rise of cases, India has started discussions with vaccine makers to develop a monkeypox vaccine.

V K Paul, member of think-tank NITI Aayog, in an exclusive interview with ANI, said government

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 27 2022 | 7:22 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com